From Forbes November 04, 2016 Professor Tomas Philipson Harris Public Policy Professor Tomas PhilipsonHarris Public Policy Professor Tomas Philipson discusses the current approval process for drugs and its ability to make all-or-nothing decisions based on limited evidence. Full coverage is available at Forbes. Upcoming Events More events SDG (Sustainable Development Goals) Challenge Program for High School Students: Navigating US College Admissions with Ranjan Daniels Mon., April 29, 2024 | 8:00 AM Data & Policy Summer Scholar (DPSS) Roundtable with Alumni Mon., April 29, 2024 | 7:30 PM Harris Evening Master's Program Class Visit—Economic Analysis III: Public Finance and Budgeting With Professor Justin Marlowe Tue., April 30, 2024 | 5:45 PM Convene 311 West Monroe St. 2nd Floor Reception Chicago, IL 60606 United States
April 08, 2024 How Medicare beneficiaries with Part D plans can help ensure their medications are covered